Investigation of MMP-2 and -9 in a highly invasive A431 tumor cell sub-line selected from a boyden chamber assay

Anticancer Research

Volumn 28, Issue 4 B, 2008, Pages 2109-2120

  Kao, Wen Te ^a   Lin, Chun Yu ^a   Lee, Lung Ta ^b   Lee, Ping Ping H ^a   Hung, Chin Chun ^a   Lin, Yung Sheng ^a   Chen, Shih Hsun ^a   Ke, Ferng Chun ^a   Hwang, Jiuan Jiuan ^c   Lee, Ming Ting ^a,d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TOKO UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

Author keywords

A431; Boyden chamber assay; FAK; MMP 2; MMP 9

Indexed keywords

FIBRONECTIN; FOCAL ADHESION KINASE; GELATIN; GELATINASE A; GELATINASE B; VINCULIN;

ARTICLE; ASSAY; BOYDEN CHAMBER ASSAY; CANCER INVASION; CELL ISOLATION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TUMOR CELL LINE; ZYMOGRAPHY;

CELL ADHESION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; DIFFUSION CHAMBERS, CULTURE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASMS; PHOSPHORYLATION; VINCULIN;

EID: 49049121616     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Okoh V, Young GD, Winokur TS and Garver RI Jr: A novel assay for the quantification of invasion from raft cultures of lung carcinomas. Clin Exp Metastasis 22: 1-6, 2005.
2. Liotta LA: Cancer cell invasion and metastasis. Medicine. Sci Am 266: 54-59, 62-63, 1992.
3. Matrisian LM: Metalloproteinases and their inhibitors in matrix remolding. Trends Genet 6: 121-125, 1990.
4. Leppä S, Saarto T, Vehmanen L, Blomqvist C and Elomaa IA: High serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma. Clin Cancer Res 10: 1057-1063, 2004.
5. Egeblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nature Rev Cancer 2: 161-174, 2002.
6. Huang YT, Hwang JJ, Lee LT, Liebow C, Lee PPH, Ke FC, Lo TB, Schally AV and Lee MT: Inhibitory effects of a luteinizing hormone-releasing hormone agonist on basal and epidermal growth factor-induced cell proliferation and metastasis-associated properties in human epidermoid carcinoma A431 cells. Int J Cancer 99: 505-513, 2002.
7. Kanadaswami C, Lee LT, Lee PPH, Hwang JJ, Ke FC, Huang YT and Lee MT: The antitumor activity of flavonoids. In Vivo 79: 895-910, 2005.
8. Wagenaar-Miller RA, Gordon L and Matrisian LM: Matrix metalloproteinases in colorectal cancer: Is it worth talking about? Cancer Met Rev 23(1-2): 119-135, 2004.
9. Zamora PO, Danielson KG and Hosick HL: Invasion of endothelial cell monolayers on collagen gels by cells from mammary tumor spheroids. Cancer Res 40: 4631-4639, 1980.
10. Starkey JR, Hosick HL, Stanford DR and Liggitt HD: Interaction of metastatic tumor cells with bovine lens capsule basement membrane. Cancer Res 4: 1585-1594, 1984.
11. Kirchner J, Kam Z, Tzur G, Bershadsky AD and Geiger B: Live-cell monitoring of tyrosine phosphorylation in focal adhesions following microtubule disruption. J Cell Sci 116: 975-986, 2003.
12. Tilghman RW, Slack-Davis JK, Sergina N, Martin KH, Iwanicki M, Hershey ED, Beggs HE, Reichardt LF and Parsons JT: Focal adhesion kinase is required for the spatial organization of the leading edge in migrating cells. J Cell Sci 118: 2613-2623, 2005.
13. Hanada M, Tanaka K, Matsumoto Y, Nakatani F, Sakimura, Matsunobu T, Li X, Okada T, Nakamura T, Takasaki M and Iwamoto Y: Focal adhesion kinase is activated in invading fibrosarcoma cells and regulates metastasis. Clin Exp Metastasis 22: 485-494, 2005
14. Schlaepfer DD, Mitra SK and Ilic D: Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim Biophys Acta 1692: 77-102, 2004.
15. Hauck, CR, Sieg DJ, Hsia DA, Loftus JC, Garrde WA, Monia B and Schlaepfer DD: Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. Cancer Res 61: 7079-7090, 2001.
16. Huang YT, Lee LT, Lee PPH, Lin YS and Lee MT: Targeting of focal adhesion kinase by flavonoids and small-interfering RNAs reduces tumor-cell migration ability. Anticancer Res 25: 2017-2026, 2005.
17. Mon NN, Hasegawa H, Thant A, Huang P, Tanimura Y, Senga T and Hamaguchi M: A role for focal adhesion kinase signaling in tumor necrosis factor-a-dependent matrix metalloproteinase-9 production in a cholangiocarcinoma cell line, CCKS1. Cancer Res 66: 6778-6784, 2006.
18. Sein TT, Thant AA, Hiraiwa,Y Arnin ARM, Sohara Y, Liu Y, Matsuda S, Yamamoto T and Hamaguchi M: A role for FAK in the concanavalin A-dependent secretion of matrix metalloproteinase-2 and -9. Oncogene 19: 5539-5542, 2000.
19. Mosmann TJ: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity. J Immunol Methods 65: 55-63, 1993.
20. Saiki H, Fuji J, Yoneda F, Abe M, Nakajima M and Tsuruo T: Role of aminopeptidase N(CDlS) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer 54: 137-143, 1993.
21. Heussen C and Dowdle EB: Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrate. Anal Biochem 102: 196-202, 1980.
22. Huttenlocher A, Ginsberg MH and Horwitz AF: Modulation of cell migration by integrin-mediated cytoskeletal linkages and ligand-binding affinity. J Cell Biol 134: 1551-1562, 1996.
23. Samuels ML, Weber MJ, Bishop JM and McMahon M: Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol Cell Biol 13: 6241-6252, 1993.
24. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the protein-dye binding. Anal Biochem 72: 248-254, 1976.
25. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4a. Nature 227: 680-685, 1970.
26. Towbin H, Staehelin T and Gordon J: Electrophoretic transfer of proteins from poly-acrylamide gels to nitrocellular sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1976.
27. Sieg DJ, Hauck CR and Schlaepfer DD: Required role of focal adhesion kinases (FAK) for integrin-stimulated cell migration. J Cell Sci 112: 2677-2691, 1999.
28. Liabakk, NB, Talbot I, Smith RA, Wilkinson K and Balkwill FR: Matrix metalloproteinases 2 (MMP-2) and matrix metallo-proteinase 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res 56: 190-196, 1996.
29. Naylor MS, Stamp GW, Davies BD and Balkwill FR: Expression and activity of MMPs and their regulators in ovarian cancer. Int J Cancer 58: 50-56, 1994.
30. Christofori G: New signals from the invasive front. Nature 441: 444-450, 1994.
31. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG and Frame MC: The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nature Rev Cancer 5: 505-515, 2005.
32. Christofori G: The role of the cell-adhesion molecule E-cadherin as a tumor suppressor-gene. Trends Biochem Sci 24: 73-76, 1999.
33. Huang YT, Hwang JJ, Lee PPH, Ke FC, Huang JH, Huang CJ, Kandaswami C, Middleton E Jr and Lee MT: Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br J Pharmacol 128: 999-1010, 1999.
34. Svensson S, Jirström K, Rydén L, Roos G, Emdin S, Ostrowski MC and Landberg G: ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis. Oncogene 24: 4370-4379, 2005.
35. Joslin EJ, Opresko LK, Wells A, Wiley HS and Lauffenburger DA: EGF-receptor-mediated mammary epithelial cell migration is driven by sustained ERK signaling from autocrine stimulation. J Cell Sci 720: 3688-3699, 2007.